NYSE:NUVB.WS (USA)
Â
Warrants (07/07/2027)
$
0.12
-0.015 (-11.32%)
03:48 PM EST
Business Description
Nuvation Bio Inc
NAICS : 541713
SIC : 2834
ISIN : US67080N1019
Share Class Description:
NUVB.WS: Warrants (07/07/2027)Description
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 169.02 | |||||
Equity-to-Asset | 0.97 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.04 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -31.5 | |||||
3-Year EPS without NRI Growth Rate | -22.4 | |||||
3-Year FCF Growth Rate | -22.8 | |||||
3-Year Book Growth Rate | 40.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 38.58 | |||||
Quick Ratio | 38.58 | |||||
Cash Ratio | 37.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 0.06 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -11.19 | |||||
ROA % | -10.88 | |||||
ROIC % | -1259.87 | |||||
ROC (Joel Greenblatt) % | -2187.03 | |||||
ROCE % | -15.12 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-FCF | -2.54 | |||||
FCF Yield % | -8.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:NUVB.WS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nuvation Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0 - 1.1 | ||
Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nuvation Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nuvation Bio Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Nuvation Bio Inc Frequently Asked Questions
What is Nuvation Bio Inc(NUVB.WS)'s stock price today?
The current price of NUVB.WS is $0.12. The 52 week high of NUVB.WS is $1.10 and 52 week low is $0.00.
When is next earnings date of Nuvation Bio Inc(NUVB.WS)?
The next earnings date of Nuvation Bio Inc(NUVB.WS) is 2024-08-02 Est..
Does Nuvation Bio Inc(NUVB.WS) pay dividends? If so, how much?
Nuvation Bio Inc(NUVB.WS) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |